Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>G Sachs Expects BUD APAC (01876.HK) to Return to Rev. Growth in CN This Yr, Keeps Buy Rating
Recommend 2 Positive 3 Negative 2 |
||||
|
||||
|
BUD APAC (01876.HK) experienced a YoY decline of 6.1% in organic sales and 9.8% in EBITDA for 2025, Goldman Sachs released a research report saying. The China market was the main drag (with sales volume down 8.6% YoY and average selling price down 3% YoY), but there are signs of stabilization starting from 4Q25 (sales volume decline narrowed to 3.9%). Looking ahead to 2026, the Group expected to face slight challenges from commodity price costs, partially offset by cost management measures. The broker estimated that the China market will return to positive revenue growth within the year, with stable average selling prices and a 2% YoY increase in sales volume. Therefore, Goldman Sachs kept rating at Buy and a target price of $8.4. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
